Renhe Capital
Overview
Renhe Capital is a private equity firm that focuses on equity investment and private placement of listed companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Hongji Chuangneng Technology (Guangzhou) Co., Ltd. | Oct 2022 | Series B | Co-investor |
| Shanghai Shenli Technology Co., Ltd. | Dec 2021 | Series C Extension | Co-investor |
| Shenzhen Guyan New Material Technology Co., Ltd. | Jul 2024 | Angel | Lead |
| Shanghai Maxim Fuel Cell Co., Ltd. | Jul 2019 | Seed | Co-investor |
| Beijing Innova Medicine Technology Co., Ltd. | Mar 2026 | Strategic | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Renhe Capital based?
Renhe Capital is headquartered in Shenzhen, China.
When was Renhe Capital founded?
Renhe Capital was founded in 2012.
How many portfolio companies does Renhe Capital have?
Renhe Capital has 8 portfolio companies in Caplight's dataset.
What are some companies in Renhe Capital's portfolio?
Portfolio companies visible on Caplight include Hongji Chuangneng Technology (Guangzhou) Co., Ltd., Shanghai Shenli Technology Co., Ltd., Shenzhen Guyan New Material Technology Co., Ltd., Shanghai Maxim Fuel Cell Co., Ltd., Beijing Innova Medicine Technology Co., Ltd..
What was Renhe Capital's most recent investment shown here?
Renhe Capital's most recent investment in this portfolio sample was in Beijing Innova Medicine Technology Co., Ltd. in 2026.
What sectors does Renhe Capital focus on?
Renhe Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech, Energy & Sustainability, Energy & Sustainability, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Renhe Capital focus on?
Stage focus information for Renhe Capital is not publicly available.